Naltrexone long acting formulations and methods of use

Details for Australian Patent Application No. 2005239989 (hide)

Owner Alkermes, Inc.

Inventors Ehrich, Elliot

Agent Pizzeys

Pub. Number AU-B-2005239989

PCT Pub. Number WO2005/107753

Priority 60/564,542 22.04.04 US; 11/083,167 17.03.05 US

Filing date 18 March 2005

Wipo publication date 17 November 2005

Acceptance publication date 29 May 2008

International Classifications

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A01N 25/00 (2006.01) Biocides

A61F 2/00 (2006.01) Filters

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/107753 Priority application(s): WO2005/107753

29 May 2008 Application Accepted

  Published as AU-B-2005239989

25 September 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005239990-Oxygen scavenging film with cyclic olefin copolymer

2005239985-Therapeutic enzyme formulations and uses thereof